journal article·2022-02

Self-sufficient copper peroxide loaded pKa-tunable nanoparticles for lysosome-mediated chemodynamic therapy

Hongzhang Deng, Zuo Yang, Xiaoyu Pang, Caiyan Zhao, Jie Tian, Zhongliang Wang, Xiaoyuan Chen

Nano Today· Volume 42
Publisher page

Abstract

Abstract Chemodynamic therapy (CDT) has recently gained much attention for Fenton chemistry-mediated cancer treatment, but the anti-tumor efficacy of CDT suffers from insufficient amount of endogenous H2O2 and inefficient decomposition of metal oxides to catalytic ions. Although tremendous progress has been made to increase the amount of H2O2 in the tumor region, the antitumor activity of CDT remains limited due to the suboptimal ionization to release enough amounts of catalytic ions for converting endogenous H2O2 to reactive oxygen species (e.g. highly toxic hydroxyl radical ·OH). Here, a series of nanoparticles with tunable acid dissociation constant (pKa) values from 5.2 to 6.2 were prepared to load H2O2 self-supplying copper peroxide, which can be used to trap copper peroxide in acidic lysosome to produce ample catalytic ions that convert self-supplied H2O2 into ·OH by a robust Fenton reaction. The highly reactive ·OH effectively permeate the lysosomal membrane through lipid peroxidation and thus kill tumor cells in a lysosome-mediated manner. Most importantly, the Fenton reaction is processed inside the lysosomal compartment, which avoids the cytoplasmic antioxidants such as glutathione (GSH) to scavenge ·OH. Overall, this work provides a new strategy to enhance CDT efficacy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Recent progress of chemodynamic therapy-induced combination cancer therapy10.1016/j.nantod.2020.100946 ↗
2. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
3. Chemodynamic therapy: tumour microenvironment‐mediated fenton and fenton‐like reactions10.1002/anie.201805664 ↗
4. Ferrous-cysteine–phosphotungstate nanoagent with neutral pH fenton reaction activity for enhanced cancer chemodynamic therapy10.1039/C8MH01176A ↗
5. Programmed degradation of a hierarchical nanoparticle with redox and light responsivity for self-activated photo-chemical enhanced chemodynamic therapy10.1016/j.biomaterials.2019.119498 ↗
6. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy10.1038/s41467-020-15591-4 ↗
7. A metal–polyphenol‐coordinated nanomedicine for synergistic cascade cancer chemotherapy and chemodynamic therapy10.1002/adma.201906024 ↗
8. Synthesis of MoSe2/CoSe2 nanosheets for NIR‐enhanced chemodynamic therapy via synergistic in‐situ H2O2 production and activation
9. Magnetic targeting10.1021/acsnano.8b05042 ↗
10. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles10.1038/nnano.2007.260 ↗
11. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species10.1021/acs.nanolett.6b04269 ↗
12. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
13. Bioorthogonal coordination polymer nanoparticles with aggregation‐induced emission for deep tumor‐penetrating radio‐ and radiodynamic therapy
14. An ultrasound‐excitable aggregation‐induced emission dye for enhanced sonodynamic therapy of tumors
15. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2 -based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
16. Molecular self-assembly of bioorthogonal aptamer-prodrug conjugate micelles for hydrogen peroxide and pH-independent cancer chemodynamic therapy10.1021/jacs.9b10755 ↗
17. Light‐triggered transformable ferrous ion delivery system for photothermal primed chemodynamic therapy10.1002/anie.202015379 ↗
18. Multicomponent transition metal dichalcogenide nanosheets for imaging-guided photothermal and chemodynamic therapy
19. A multifunctional cascade bioreactor based on hollow-structured Cu2 MoS4 for synergetic cancer chemo-dynamic therapy/starvation therapy/phototherapy/immunotherapy with remarkably enhanced efficacy10.1002/adma.201905271 ↗
20. An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion10.1021/acs.nanolett.8b03178 ↗
21. Recent advances in nanomaterial‐based nanoplatforms for chemodynamic cancer therapy
22. A redox-triggered C-centered free radicals nanogenerator for self-enhanced magnetic resonance imaging and chemodynamic therapy10.1016/j.biomaterials.2020.120457 ↗
23. Engineering multifunctional RNAi nanomedicine to concurrently target cancer hallmarks for combinatorial therapy10.1002/anie.201710144 ↗
24. Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy
25. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy10.1021/jacs.9b03457 ↗
26. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
27. Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome10.1021/acsnano.5b06175 ↗
28. Co(OH)2@PANI hybrid nanosheets with 3D networks as high‐performance electrocatalysts for hydrogen evolution reaction10.1002/adma.201904101 ↗
29. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions10.1002/anie.201805664 ↗
30. Biomimetic CoO@AuPt nanozyme responsive to multiple tumor microenvironmental clues for augmenting chemodynamic therapy10.1016/j.biomaterials.2020.120279 ↗
31. A smart photosensitizer-manganese dioxide nanosystem for enhanced photodynamic therapy by reducing glutathione levels in cancer cells10.1002/anie.201510748 ↗
32. Copper(II)-graphitic carbon nitride triggered synergy: improved ROS generation and reduced glutathione levels for enhanced photodynamic therapy10.1002/anie.201605509 ↗
33. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth10.1038/nm.4232 ↗
34. Magnetically guided delivery of DHA and Fe ions for enhanced cancer therapy based on pH-responsive degradation of DHA-loaded Fe3O4@C@MIL-100(Fe) nanoparticles10.1016/j.biomaterials.2016.08.039 ↗
35. Intelligent Fe–Mn layered double hydroxides nanosheets anchored with upconversion nanoparticles for oxygen‐elevated synergetic therapy and bioimaging10.1002/smll.202001343 ↗
36. Biological and environmental transformations of copper-based nanomaterials10.1021/nn403080y ↗
37. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase10.1016/j.ccr.2013.08.003 ↗
38. Combating apoptosis and multidrug resistant cancers by targeting lysosomes10.1016/j.canlet.2010.05.021 ↗
39. NAADP mobilizes calcium from acidic organelles through two-pore channels10.1038/nature08030 ↗
40. Lysosomes as a therapeutic target10.1038/s41573-019-0036-1 ↗
41. Stat3 controls lysosomal-mediated cell death in vivo10.1038/ncb2171 ↗
42. Lysosomal pathways to cell death and their therapeutic applications10.1016/j.yexcr.2012.03.005 ↗
43. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase10.1016/j.ccr.2013.08.003 ↗
44. Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation10.1016/j.ajpath.2010.10.030 ↗
45. LAPTM4B facilitates late endosomal ceramide export to control cell death pathways10.1038/nchembio.1889 ↗
46. Membrane transport in the endocytic pathway10.1016/0955-0674(95)80013-1 ↗
47. Nanoparticle drug delivery can reduce the hepatotoxicity of therapeutic cargo
48. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo10.1016/j.biomaterials.2013.07.084 ↗
49. Therapeutic use of H2O2-responsive anti-oxidant polymer nanoparticles for doxorubicin-induced cardiomyopathy10.1016/j.biomaterials.2014.03.084 ↗
50. Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer10.1016/j.biomaterials.2018.05.042 ↗